Recursion Pharma Inc (Class A) - RXRX - stock price prediction, stock price target, analyst ratings from 8 analysts

Recursion Pharma Inc (Class A) has a share price target of US$ 7, revenue growth forecast of -10.9%, and profit growth estimate of 28.3% for FY26, based on top 8 analyst calls.